Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults: A Randomized Controlled Trial
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
CONTEXT: Although the cost-effectiveness and cost-benefit of influenza vaccination are well established for persons aged 65 years or older, the benefits for healthy adults younger than 65 years are less clear. OBJECTIVE: To evaluate the effectiveness and cost-benefit of influenza vaccine in preventing influenza-like illness (ILI) and reducing societal costs of ILI among healthy working adults. DESIGN: Double-blind, randomized, placebo-controlled trial conducted during 2 influenza seasons. SETTING AND PARTICIPANTS: Healthy adults aged 18 to 64 years and employed full-time by a US manufacturing company (for 1997-1998 season, n = 1184; for 1998-1999 season, n = 1191). INTERVENTIONS: For each season, participants were randomly assigned to receive either trivalent inactivated influenza vaccine (n = 595 in 1997-1998 and n = 587 in 1998-1999) or sterile saline injection (placebo; n = 589 in 1997-1998 and n = 604 in 1998-1999). Participants in 1997-1998 were rerandomized if they participated in 1998-1999. MAIN OUTCOME MEASURES: Influenza-like illnesses and associated physician visits and work absenteeism reported in biweekly questionnaires by all participants, and serologically confirmed influenza illness among 23% of participants in each year (n = 275 in 1997-1998; n = 278 in 1998-1999); societal cost of ILI per vaccinated vs unvaccinated person. RESULTS: For 1997-1998 and 1998-1999, respectively, 95% (1130/1184) and 99% (1178/1191) of participants had complete follow-up, and 23% in each year had serologic testing. In 1997-1998, when the vaccine virus differed from the predominant circulating viruses, vaccine efficacy against serologically confirmed influenza illness was 50% (P =.33). In this season, vaccination did not reduce ILI, physician visits, or lost workdays; the net societal cost was $65.59 per person compared with no vaccination. In 1998-1999, the vaccine and predominant circulating viruses were well matched. Vaccine efficacy was 86% (P =.001), and vaccination reduced ILI, physician visits, and lost workdays by 34%, 42%, and 32%, respectively. However, vaccination resulted in a net societal cost of $11.17 per person compared with no vaccination. CONCLUSION: Influenza vaccination of healthy working adults younger than 65 years can reduce the rates of ILI, lost workdays, and physician visits during years when the vaccine and circulating viruses are similar, but vaccination may not provide overall economic benefits in most years. JAMA. 2000;284:1655-1663.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
The Efficacy of Influenza Vaccine in Elderly Persons: A Meta-Analysis and Review of the Literature
Gross, P. A., Hermogenes, A. W., Sacks, H. S., Lau, J., & Levandowski, R. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-7-199510010-00008 · Cited by 1,100
Govaert, T. M. E. (1994) · JAMA · doi:10.1001/jama.1994.03520210045030 · Cited by 867
Viruses and bacteria in the etiology of the common cold
Mäkelä, M. J., Puhakka, T., Ruuskanen, O., Leinonen, M., Saikku, P., Kimpimäki, M., Blomqvist, S., Hyypiä, T., & Arstila, P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.539-542.1998 · Cited by 768 · cited 1×
“In our study, as in most studies, only a minority of the respiratory illnesses among adults were due to influenza.(25,37-39) Third, in approximately 1 of every 10 years, there is a poor antigenic match between vaccine strains and the predominant circulating influenza viruses (Nancy J.”
ResultThe Effectiveness of Vaccination against Influenza in Healthy, Working Adults
Nichol, K. L., Lind, A., Margolis, K. L., Murdoch, M., McFadden, R., Hauge, M., Magnan, S., & Drake, M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510053331401 · Cited by 673
Effectiveness of Influenza Vaccine in Health Care Professionals: A Randomized Trial
Wilde, J. A., McMillan, J. A., Serwint, J., Butta, J., O'Riordan, M. A., & Steinhoff, M. C. (1999) · JAMA · doi:10.1001/jama.281.10.908 · Cited by 599
SERIOUS MORBIDITY AND MORTALITY ASSOCIATED WITH INFLUENZA EPIDEMICS
GLEZEN, W. P. (1982) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036250 · Cited by 449
ASSESSING VACCINE EFFICACY IN THE FIELD
ORENSTEIN, W. A., BERNIER, R. H., & HINMAN, A. R. (1988) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036023 · Cited by 385
Keech, M., Scott, A. J., & Ryan, P. J. J. (1998) · Occupational Medicine · doi:10.1093/occmed/48.2.85 · Cited by 383
IMPACT OF EPIDEMIC TYPE A INFLUENZA IN A DEFINED ADULT POPULATION
BARKER, W. H., & MULLOOLY, J. P. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113052 · Cited by 370
Cited by
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Molinari, N.-A. M., Ortega-Sanchez, I. R., Messonnier, M. L., Thompson, W. W., Wortley, P. M., Weintraub, E., & Bridges, C. B. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.03.046 · Cited by 1,722
Self-citationGrohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
Broad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
Vaccines for preventing influenza in healthy adults
Jefferson, T., Di Pietrantonj, C., Rivetti, A., Bawazeer, G. A., Al-Ansary, L. A., & Ferroni, E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001269.pub4 · Cited by 896
Guidelines for the management of adult lower respiratory tract infections
Woodhead, M., Blasi, F., Ewig, S., Huchon, G., Leven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., & Verheij, T. J. M. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00055705 · Cited by 895
Influenza vaccine: The challenge of antigenic drift
CARRAT, F., & FLAHAULT, A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.027 · Cited by 708
Nicholson, K. G., Wood, J. M., & Zambon, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14854-4 · Cited by 691
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Olsen, S. J., Karron, R. A., Jernigan, D. B., & Bresee, J. S. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6505a1 · Cited by 593
Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population
(2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.3.265 · Cited by 543
Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
Steel, J., Lowen, A. C., Wang, T. T., Yondola, M., Gao, Q., Haye, K., García-Sastre, A., & Palese, P. (2010) · mBio · doi:10.1128/mbio.00018-10 · Cited by 533
Pearson, M. L., Bridges, C. B., & Harper, S. A. (2006) · PsycEXTRA Dataset · doi:10.1037/e506932006-001 · Cited by 529
Self-citationMortality benefits of influenza vaccination in elderly people: an ongoing controversy
Simonsen, L., Taylor, R. J., Viboud, C., Miller, M. A., & Jackson, L. A. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70236-0 · Cited by 520
Antibody landscapes after influenza virus infection or vaccination
Fonville, J. M., Wilks, S. H., James, S. L., Fox, A., Ventresca, M., Aban, M., Xue, L., Jones, T. C., H., L. N. M., T., P. Q., et al. (2014) · Science · doi:10.1126/science.1256427 · Cited by 474
Guidelines for the management of adult lower respiratory tract infections - Summary
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03602.x · Cited by 468
Influenza in the acute hospital setting
Salgado, C. D., Farr, B. M., Hall, K. K., & Hayden, F. G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00221-9 · Cited by 417
Wang, K., Wong, E. L. Y., Ho, K. F., Cheung, A. W. L., Chan, E. Y. Y., Yeoh, E. K., & Wong, S. Y. S. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.09.021 · Cited by 393
Tricco, A. C., Chit, A., Soobiah, C., Hallett, D., Meier, G., Chen, M. H., Tashkandi, M., Bauch, C. T., & Loeb, M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-153 · Cited by 390
IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry
Feeley, E. M., Sims, J. S., John, S. P., Chin, C. R., Pertel, T., Chen, L.-M., Gaiha, G. D., Ryan, B. J., Donis, R. O., Elledge, S. J., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002337 · Cited by 387
Severe Community-acquired Pneumonia Due to Staphylococcus aureus , 2003–04 Influenza Season
Hageman, J. C., Uyeki, T. M., Francis, J. S., Jernigan, D. B., Wheeler, J. G., Bridges, C. B., Barenkamp, S. J., Sievert, D. M., Srinivasan, A., Doherty, M. C., et al. (2006) · Emerging infectious diseases · doi:10.3201/eid1206.051141 · Cited by 379
“Moreover, studies have demonstrated that influenza vaccination can decrease the incidence of upper respiratory infections and lessen the need for antimicrobial drug use in healthy adults (24,25).”
BackgroundSelf-citationBurden of illness in Parkinson's disease
Huse, D. M., Schulman, K., Orsini, L., Castelli‐Haley, J., Kennedy, S., & Lenhart, G. (2005) · Movement Disorders · doi:10.1002/mds.20609 · Cited by 335
Influenza virus hemagglutinin stalk-based antibodies and vaccines
Krammer, F., & Palese, P. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.07.007 · Cited by 326
Fan, J., Liang, X., Horton, M. S., Perry, H. C., Citron, M. P., Heidecker, G. J., Fu, T.-M., Joyce, J., Przysiecki, C. T., Keller, P. M., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.02.021 · Cited by 315
Belongia, E. A., Kieke, B. A., Donahue, J. G., Greenlee, R. T., Balish, A., Foust, A., Lindstrom, S., Shay, D. K., & Marshfield Influenza Study Group (2009) · The Journal of Infectious Diseases · doi:10.1086/595861 · Cited by 312
Prevention of Antigenically Drifted Influenza by Inactivated and Live Attenuated Vaccines
Ohmit, S. E., Victor, J. C., Rotthoff, J. R., Teich, E. R., Truscon, R. K., Baum, L. L., Rangarajan, B., Newton, D. W., Boulton, M. L., & Monto, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061850 · Cited by 295
Mandatory Influenza Vaccination of Health Care Workers: Translating Policy to Practice
Babcock, H. M., Gemeinhart, N., Jones, M., Dunagan, W. C., & Woeltje, K. F. (2010) · Clinical Infectious Diseases · doi:10.1086/650752 · Cited by 289
Toward a Universal Influenza Virus Vaccine: Prospects and Challenges
Pica, N., & Palese, P. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-120611-145115 · Cited by 284
Galvani, A. P., Reluga, T. C., & Chapman, G. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606774104 · Cited by 282
Requiring influenza vaccination for health care workers: seven truths we must accept
POLAND, G., TOSH, P., & JACOBSON, R. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.043 · Cited by 279
Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines
Monto, A. S., Ohmit, S. E., Petrie, J. G., Johnson, E., Truscon, R., Teich, E., Rotthoff, J., Boulton, M., & Victor, J. C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808652 · Cited by 277
Kuster, S. P., Shah, P. S., Coleman, B. L., Lam, P.-P., Tong, A., Wormsbecker, A., & McGeer, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026239 · Cited by 267
The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines
Nichol, K. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00070-7 · Cited by 265
Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination
Olivares, M., Díaz-Ropero, M. P., Sierra, S., Lara-Villoslada, F., Fonollá, J., Navas, M., Rodríguez, J. M., & Xaus, J. (2007) · Nutrition · doi:10.1016/j.nut.2007.01.004 · Cited by 264
Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses
Sandbulte, M. R., Westgeest, K. B., Gao, J., Xu, X., Klimov, A. I., Russell, C. A., Burke, D. F., Smith, D. J., Fouchier, R. A. M., & Eichelberger, M. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113801108 · Cited by 261
Self-citationCost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza
Nichol, K. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.5.749 · Cited by 258
Mandatory Influenza Vaccination of Healthcare Workers: A 5-Year Study
Rakita, R. M., Hagar, B. A., Crome, P., & Lammert, J. K. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/656210 · Cited by 253
A simple and valid tool distinguished efficacy from effectiveness studies
Gartlehner, G., Hansen, R. A., Nissman, D., Lohr, K. N., & Carey, T. S. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.01.011 · Cited by 207
Cost-Benefit Analysis of In-Hospital Influenza Vaccination of Postpartum Women
Ding, Y., Zangwill, K. M., Hay, J. W., Allred, N. J., & Yeh, S. H. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318242af27 · Cited by 16
Metadata
- Authors
- Bridges, C. B., Thompson, W. W., Meltzer, M. I., Reeve, G. R., Talamonti, W. J., Cox, N. J., Lilac, H. A., Hall, H., Klimov, A., & Fukuda, K.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2000-10-04
- Volume
- 284
- Issue
- 13
- Pages
- 1655
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1987750593
- Cited by
- 651
- References
- 27
- FWCI
- 19.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.